Clinical trial
Investigation of Safety of WS®1442 in Slightly Overweight Subjects With Pilot Assessment of Pharmacodynamic Effects of WS®1442 on Endothelial Function
NCT00982501 is registered in ClinicalTrials.gov with Dr. Willmar Schwabe GmbH & Co. KG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of Safety of WS®1442 in Slightly Overweight Subjects With Pilot Assessment of Pharmacodynamic Effects of WS®1442 on Endothelial Function
- Lead sponsor
- Dr. Willmar Schwabe GmbH & Co. KG
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- February 28, 2011
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.